| Mr Thanikachalam Arunagiri, RPH | |
|
13920 58th Ave, Flushing, NY 11355-5311 | |
| (347) 610-6834 | |
| Not Available |
| Full Name | Mr Thanikachalam Arunagiri |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 13920 58th Ave, Flushing, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023320272 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 048319 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Thanikachalam Arunagiri, RPH 13920 58th Ave, Flushing, Flushing, NY 11355-5311 Ph: (347) 610-6834 | Mr Thanikachalam Arunagiri, RPH 13920 58th Ave, Flushing, NY 11355-5311 Ph: (347) 610-6834 |
News Archive
Amgen today announced detailed results from a new biomarker analysis of the pivotal Phase 3 "408" trial of Vectibix® (panitumumab) plus best supportive care compared to BSC alone. The analysis used massively parallel, next-generation sequencing technology to investigate whether mutations in nine genes known to be mutated in colorectal cancer, including the previously unanalyzed exon 3 mutation of the KRAS gene, are predictive of response to Vectibix in metastatic colorectal cancer.
UBM Medica US announces that Cancer Network, a leading online community for oncologists and others who treat cancer and the online home of the journal ONCOLOGY, presents exclusive coverage of the European Society for Medical Oncology (ESMO) 2014 Congress, held September 26–30 in Madrid, Spain.
Reporters examine which provisions - such as the public option or cost control provisions - may be included as House and Senate negotiators try to meld various Democratic health reform bills.
A new technique has been identified that quickly and cheaply recognizes illegal designer drugs that normally evade detection.
In an examination of a type of treatment for allergic rhinitis and asthma that is used in Europe but not approved by the U.S. Food and Drug Administration, researchers found moderate strength in the evidence from previous studies to support the use of sublingual immunotherapy for the treatment of these conditions, according to an article in the March 27 issue of JAMA.
› Verified 5 days ago
Mrs. Parimala Rani Gaddam, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14919 Union Tpke, Flushing, NY 11367 Phone: 718-380-5440 Fax: 718-380-3028 | |
Helen H Chon, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14246 Roosevelt Ave, Flushing, NY 11354 Phone: 718-888-0808 | |
Mr. Stuart Pomper, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6850 Main St, Flushing, NY 11367 Phone: 718-544-4656 Fax: 718-261-2114 | |
Gabriel S Lee, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4059 College Point Blvd, Flushing, NY 11354 Phone: 718-888-9338 Fax: 718-888-9299 | |
Dr. Wenli Xiao, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13347 Sanford Ave, Flushing, NY 11355 Phone: 718-460-8329 | |
Mr. Khanh T Ho, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14429 Northern Blvd, Flushing, NY 11354 Phone: 718-886-6645 | |
Pauline Yuen Wan Chow, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15802 Union Tpke, Flushing, NY 11366 Phone: 718-380-8259 |